Lucy N. is a seasoned finance professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Senior Director of Financial Planning & Analysis at Akero Therapeutics since December 2020, Lucy has previously held significant roles such as Finance Manager for Therapeutics, Research, & Business Development at 23andMe and various senior financial analyst positions at Gilead Sciences. Lucy's career began as a Research Associate at Oncomed Pharmaceuticals and includes financial analyst roles at Redwood Capital Advisors LLC and Western National Capital Partners. Academically, Lucy holds Bachelor of Science degrees in Management Science and Biology from UC San Diego, complemented by coursework through UC Berkeley Extension.
This person is not in any teams
This person is not in any offices